This tumor growth inhibition was paralleled by a significant (24%) reduction of the Ki-67 proliferation index (Figure 8A, right panel), showing a major impact of CD95-related inflammatory mechanisms stimulating human pancreatic cancer cell proliferation under in vivo conditions. This evidence concerns the gene FAS and neoplasm.